162 related articles for article (PubMed ID: 28860931)
41. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
Baskett A; Barton MH; Norton N; Anders B; Moore JN
Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
[TBL] [Abstract][Full Text] [Related]
42. Pentoxifylline triggers autophagy via ER stress response that interferes with Pentoxifylline induced apoptosis in human melanoma cells.
Sharma K; Ishaq M; Sharma G; Khan MA; Dutta RK; Majumdar S
Biochem Pharmacol; 2016 Mar; 103():17-28. PubMed ID: 26793997
[TBL] [Abstract][Full Text] [Related]
43. Pentoxifylline: a new agent for intermittent claudication.
Baker DE; Campbell RK
Drug Intell Clin Pharm; 1985 May; 19(5):345-8. PubMed ID: 3891279
[TBL] [Abstract][Full Text] [Related]
44. Differential influence of pentoxifylline on murine colon adenocarcinoma- and melanoma-derived metastatic tumor development in lungs.
Lazarczyk M; Grzela T; Niderla J; Lazarczyk MA; Milewski L; Dziunycz P; Skopinski P; Golab J
Oncol Rep; 2004 May; 11(5):1121-5. PubMed ID: 15069556
[TBL] [Abstract][Full Text] [Related]
45. The effect of pentoxifylline on the lung during cardiopulmonary bypass.
Türköz R; Yörükoğlu K; Akcay A; Yilik L; Baltalarli A; Karahan N; Adanir T; Sağban M
Eur J Cardiothorac Surg; 1996; 10(5):339-46. PubMed ID: 8737690
[TBL] [Abstract][Full Text] [Related]
46. Pentoxifylline. A hydroxyl radical scavenger.
Freitas JP; Filipe PM
Biol Trace Elem Res; 1995; 47(1-3):307-11. PubMed ID: 7779563
[TBL] [Abstract][Full Text] [Related]
47. Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.
Peterson TC; Peterson MR; Wornell PA; Blanchard MG; Gonzalez FJ
Biochem Pharmacol; 2004 Jul; 68(2):395-402. PubMed ID: 15194011
[TBL] [Abstract][Full Text] [Related]
48. Prolongation of pentoxifylline aliphatic side chain positively affects the reversal of P-glycoprotein-mediated multidrug resistance in L1210/VCR line cells.
Docolomanský P; Fialová I; Barancík M; Rybár A; Breier A
Gen Physiol Biophys; 2005 Dec; 24(4):461-6. PubMed ID: 16474189
[TBL] [Abstract][Full Text] [Related]
49. The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.
Fredholm BB; Lindström K
Acta Pharmacol Toxicol (Copenh); 1986 Mar; 58(3):187-92. PubMed ID: 3012941
[TBL] [Abstract][Full Text] [Related]
50. Pentoxifylline attenuates cigarette smoke-induced overexpression of CXCR3 and IP-10 in mice.
Wang Z; Chen YW; Zhang JN; Hu XF; Peng MJ
Chin Med J (Engl); 2012 Jun; 125(11):1980-5. PubMed ID: 22884065
[TBL] [Abstract][Full Text] [Related]
51. Preventive and therapeutic anti-TNF-α therapy with pentoxifylline decreases arthritis and the associated periodontal co-morbidity in mice.
Queiroz-Junior CM; Bessoni RL; Costa VV; Souza DG; Teixeira MM; Silva TA
Life Sci; 2013 Sep; 93(9-11):423-8. PubMed ID: 23911669
[TBL] [Abstract][Full Text] [Related]
52. Effect of bucladesine, pentoxifylline, and H-89 as cyclic adenosine monophosphate analog, phosphodiesterase, and protein kinase A inhibitor on acute pain.
Salehi F; Hosseini-Zare MS; Aghajani H; Seyedi SY; Hosseini-Zare MS; Sharifzadeh M
Fundam Clin Pharmacol; 2017 Aug; 31(4):411-419. PubMed ID: 28267871
[TBL] [Abstract][Full Text] [Related]
53. [Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain].
Kitatani T; Hayashi S; Sakaguchi T
Nihon Yakurigaku Zasshi; 1985 Nov; 86(5):353-8. PubMed ID: 2417922
[TBL] [Abstract][Full Text] [Related]
54. The effects of a new xanthine derivative, 3,7-dimethyl-1(5-oxohexyl)-xanthin (pentoxifylline) on the general and cardiac haemodynamics of the intact animal.
Maxwell GM
Aust J Exp Biol Med Sci; 1975 Aug; 53(4):265-71. PubMed ID: 1230139
[TBL] [Abstract][Full Text] [Related]
55. Inhibition cAMP-phosphodiesterase in the rat heart by pentoxifylline--a new xanthine derivative.
Nandi JS; Nair KG; Deo S
Adv Myocardiol; 1980; 1():359-65. PubMed ID: 6248939
[TBL] [Abstract][Full Text] [Related]
56. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline.
Song CW; Hasegawa T; Kwon HC; Lyons JC; Levitt SH
Radiat Res; 1992 May; 130(2):205-10. PubMed ID: 1574576
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.
Badger AM; Olivera DL; Esser KM
Circ Shock; 1994 Dec; 44(4):188-95. PubMed ID: 7628060
[TBL] [Abstract][Full Text] [Related]
58. Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice.
Kinoshita T; Kobayashi S; Ebara S; Yoshimura Y; Horiuchi H; Tsutsumimoto T; Wakabayashi S; Takaoka K
Bone; 2000 Dec; 27(6):811-7. PubMed ID: 11113392
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation.
Oberyszyn TM; Tober KL; Ross MS; Robertson FM
Mol Carcinog; 1998 May; 22(1):16-25. PubMed ID: 9609097
[TBL] [Abstract][Full Text] [Related]
60. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
Al Shuwaili AH; Rasool BK; Abdulrasool AA
Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
